Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 10, 2004, Pages 1080-1091

  Sontag, Estelle ^a   Hladik, Christa ^a   Montgomery, Lisa ^a   Luangpirom, Ampa ^a   Mudrak, Ingrid ^b   Ogris, Egon ^b   White III, Charles L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Vienna Biocenter   (Austria)

Author keywords

Alzheimer disease; Amyloid; Brain; Methylation; Methyltransferase; PP2A; Tau

Indexed keywords

METHYLTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN ABALPHAC; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CHEMICAL COMPOSITION; CONTROLLED STUDY; DEMENTIA; DEMETHYLATION; DISEASE SEVERITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; METHYLATION; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION;

EID: 5644293035     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.10.1080     Document Type: Article

References (50)

1. Sontag E. Protein phosphatase 2A: The Trojan Horse of cellular signaling. Cell Signal 2001;13:7-16
2. Goedert M, Jakes R, Qi Z, Wang JH, Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem 1995;65:2804-7
3. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 1996;17:1201-7
4. Brautigan DL. Flicking the switches: Phosphorylation of serine/ threonine protein phosphatases. Semin Cancer Biol 1995;6:211-17
5. Ogris E, Gibson DM, Pallas DC. Protein phosphatase 2A subunit assembly: The catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene 1997;15:911-17
6. Bryant JC, Westphal RS, Wadzinski BE. Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit. Biochem J 1999;339:241-46
7. Evans DR, Hemmings BA. Mutation of the C-terminal leucine residue of PP2Ac inhibits PR55/B subunit binding and confers supersensitivity to microtubule destabilization in Saccharomyces cerevisiae. Mol Gen Genet 2000;264:425-32
8. Tolstykh T, Lee J, Vafai S, Stock JB. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 2000;19:5682-91
9. Wu J, Tolstykh T, Lee J, Boyd K, Stock JB, Broach JR. Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo. EMBO J 2000;19:5672-81
10. Yu XX, Du X, Moreno CS, et al. Methylation of the protein phosphatase 2A catalytic subunit is essential for association of balpha regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen. Mol Biol Cell 2001;12:185-99
11. Wei H, Ashby DG, Moreno CS, et al. Carboxymethylation of the PP2A catalytic subunit in Saccharomyces cerevisiae is required for efficient interaction with the B-type subunits Cdc55p and Rts1p. J Biol Chem 2001;276:1570-77
12. Lee J, Stock J. Protein phosphatase 2A catalytic subunit is methyl-esterified at its carboxyl terminus by a novel methyltransferase. J Biol Chem 1993;268:19192-95
13. De Baere I, Derua R, Janssens V, et al. Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. Biochemistry 1999;38:16539-47
14. George RR, Harris R, Nunn CM, Cramer R, Djordjevic S. Chaperonin assisted overexpression, purification, and characterisation of human PP2A methyltransferase. Protein Expr Purif 2002;26:266-74
15. Xie H, Clarke S. Protein phosphatase 2A is reversibly modified by methyl esterification at its C-terminal leucine residue in bovine brain. J Biol Chem 1994;269:1981-84
16. Lee J, Chen Y, Tolstykh T, Stock J. A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc Natl Acad Sci U S A 1996;93:6043-47
17. Ogris E, Du X, Nelson KC, et al. A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2a. J Biol Chem 1999;274:14382-91
18. Leulliot N, Quevillon-Cheruel S, Sorel I, et al. Structure of PPM1, a leucine carboxy methyltransferase involved in the regulation of protein phosphatase 2A activity. J Biol Chem 2004;279:8351-58
19. Martin JL, McMillan FM. SAM (dependent) I AM: The S-adenosylmethionine- dependent methyltransferase fold. Curr Opin Struct Biol 2002;12:783-93
20. Frey PA, Magnusson OT. S-Adenosylmethionine: A wolf in sheep's clothing, or a rich man's adenosylcobalamin? Chem Rev 2003;103:2129-48
21. Kins S, Crameri A, Evans DR, Hemmings BA, Nitsch RM, Gotz J. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J Biol Chem 2001;276:38193-200
22. Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 1995;69:691-98
23. Tapia R, Pena F, Arias C. Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases. Neurochem Res 1999;24:1423-30
24. He J, Yamada K, Zou LB, Nabeshima T. Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats. J Neural Transm 2001;108:1435-43
25. Planel E, Yasutake K, Fujita SC, Ishiguro K. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 2001;276:34298-306
26. Tian Q, Wang J. Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 2002;11:262-69
27. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol 2001;20:683-95
28. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001;168:402-12
29. Zhao WQ, Feng C, Alkon DL. Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts. Neurobiol Dis 2003;14:458-69
30. Sontag E, Luangpirom A, Hladik C, et al. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 2004;63:287-301
31. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: Decrease in Alzheimer disease brain. J Neurochem 1995;65:732-38
32. Eidenmuller J, Fath T, Hellwig A, Reed J, Sontag E, Brandt R. Structural and functional implications of tau hyperphosphorylation: Information from phosphorylation-mimicking mutated tau proteins. Biochemistry 2000;39:13166-75
33. Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 1996;67:1328-31
34. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
35. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993;117:132-44
36. Favre B, Zolnierowicz S, Turowski P, Hemmings BA. The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 1994;269:16311-17
37. Lee J, Chen Y, Tolstykh T, Stock J. A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc Natl Acad Sci U S A 1996;93:6043-47
38. Turowski P, Fernandez A, Favre B, Lamb NJ, Hemmings BA. Differential methylation and altered conformation of cytoplasmic and nuclear forms of protein phosphatase 2A during cell cycle progression. J Cell Biol 1995;129:397-410
39. Shi SR, Cote RJ, Taylor CR. Standardization and further development of antigen retrieval immunohistochemistry: Strategies and future goals. J Histotechnology 1999;22:177-92
40. Cummings BJ, Mason AJ, Kim RC, Sheu PC, Anderson AJ. Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging. Neurobiol Aging 2002;23:161-70
41. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992;267:564-69
42. Knopman DS. An overview of common non-Alzheimer dementias. Clin Geriatr Med 2001 ;17:281-301
43. Li X, Scuderi A, Letsou A, Virshup DM. B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol Cell Biol 2002;22:3674-84
44. Eidenmuller J, Path T, Maas T, Pool M, Sontag E, Brandt R. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem J 2001;357:759-67
45. Giannakopoulos P Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003;60:1495-500
46. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000;21:321-30
47. Martin dl V, Burda J, Toledo Lobo MV, Saunas M. Cerebral post-ischemic reperfusion-induced demethylation of the protein phosphatase 2A catalytic subunit. J Neurosci Res 2002;69:540-49
48. Mattson MP. Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 2003;139:441-44
49. Beyer K, Lao JI, Latorre P, et al. Methionine synthase polymorphism is a risk factor for Alzheimer disease. Neuroreport 2003;14:1391-94
50. Vafai SB, Stock JB. Protein phosphatase 2A methylation: A link between elevated plasma homocysteine and Alzheimer's disease. FEBS Lett 2002;518:1-4